Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ulva lactuca extract is a natural extract derived from the green macroalga **Ulva lactuca** (commonly known as sea lettuce). It is rich in **phenolic compounds, flavonoids, polysaccharides (notably ulvan), amino acids, phytosterols, triterpenes, and various volatile organic compounds**[2][4]. The extract has demonstrated notable **antioxidant activity**, **cytotoxic (anticancer) activity**—particularly against certain cancer cell lines (e.g. A549 lung cancer)[1]—and **anticholinesterase potential**, likely relevant for neurodegenerative conditions[1]. Additionally, aqueous Ulva lactuca extract exhibits **antiviral activity**, including potent inhibition of SARS-CoV-2 replication, virucidal action, and interference with viral adsorption, believed to be mediated primarily by ulvan and related complex sugars[3]. Its mechanism of action is **multimodal**, including direct antioxidant effects, enzyme inhibition (notably acetylcholinesterase and butyrylcholinesterase), cytotoxicity, and direct viral neutralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ulva lactuca extract.